Overview
Study of Metastatic Ocular Melanoma
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Charite University, Berlin, GermanyTreatments:
Gemcitabine
Treosulfan
Criteria
Inclusion Criteria:- Metastatic ocular melanoma
Exclusion Criteria:
- Prior treatment with chemotherapy
- Active 2nd malignancy
- Cerebral metastasis